or Try an Advanced Search...

    Technical Analysis for QTTB - Q32 Bio Inc.

    Grade Last Price % Change Price Change
    F 26.76 -1.91% -0.52
    QTTB closed down 6.22 percent on Wednesday, November 20, 2024, on 1.43 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical QTTB trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness -1.91%
    Multiple of Ten Bearish Other -1.91%
    Wide Bands Range Expansion -1.91%
    Below Lower BB Weakness -1.91%
    Down 3 Days in a Row Weakness -1.91%
    Down 4 Days in a Row Weakness -1.91%
    Down 5 Days in a Row Weakness -1.91%
    Lower Bollinger Band Touch Weakness -1.91%
    Oversold Stochastic Weakness -1.91%
    Fell Below 200 DMA Bearish -8.01%
    Older End-of-Day Signals for QTTB ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Lower Bollinger Band 35 minutes ago
    Down 3% 35 minutes ago
    Up 3% 35 minutes ago
    Down 2 % 35 minutes ago
    Down 1% 35 minutes ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    QTTB Chart by TradingView
    Basic chart:

    Profile

    Q32 Bio is a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. Q32 Bio's lead programs, focused on the IL-7 / TSLP receptor pathways and complement system, address immune dysregulation to help patients take back control of their lives.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Immunology Immune System Autoimmunity Autoimmune And Inflammatory Disease Complement System Thymic Stromal Lymphopoietin

    Is QTTB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 7 Q32 Bio GAAP EPS of -$1.46
    Nov 7 Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update
    Nov 5 Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference
    Oct 14 Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024
    Aug 29 Q32 Bio to Participate in Upcoming September Investor Conferences
    Aug 29 Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097
    Aug 8 Q32 Bio GAAP EPS of -$1.42
    Jul 31 Russell 2000 rise: Top 5 best, worst performers during July's rally in small-cap stocks
    Jul 9 Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic Dermatitis
    Jul 1 Q32 Bio to join Russell 3000 Index
    See more QTTB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 53.79
    52 Week Low 9.18
    Average Volume 99,827
    200-Day Moving Average 30.29
    50-Day Moving Average 44.74
    20-Day Moving Average 42.66
    10-Day Moving Average 37.75
    Average True Range 3.84
    RSI (14) 18.70
    ADX 28.3
    +DI 10.84
    -DI 35.05
    Chandelier Exit (Long, 3 ATRs) 41.65
    Chandelier Exit (Short, 3 ATRs) 37.52
    Upper Bollinger Bands 56.73
    Lower Bollinger Band 28.59
    Percent B (%b) -0.05
    BandWidth 65.95
    MACD Line -4.19
    MACD Signal Line -2.03
    MACD Histogram -2.1631
    Fundamentals Value
    Market Cap 1.58 Billion
    Num Shares 58 Million
    EPS -2.28
    Price-to-Earnings (P/E) Ratio -11.96
    Price-to-Sales 20.76
    Price-to-Book 0.46
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 33.43
    Resistance 3 (R3) 33.69 31.89 32.41
    Resistance 2 (R2) 31.89 30.33 31.77 32.06
    Resistance 1 (R1) 29.59 29.36 28.69 29.33 31.72
    Pivot Point 27.79 27.79 27.35 27.67 27.79
    Support 1 (S1) 25.49 26.23 24.59 25.23 22.84
    Support 2 (S2) 23.69 25.26 23.57 22.50
    Support 3 (S3) 21.39 23.69 22.16
    Support 4 (S4) 21.13